Neurocircuit models of obsessive-compulsive disorder: limitations and future directions for research

Carregando...
Imagem de Miniatura
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC BRASILEIRA PSIQUIATRIA
Citação
BRAZILIAN JOURNAL OF PSYCHIATRY, v.44, n.2, p.187-200, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Obsessive-compulsive disorder (OCD) is a common psychiatric condition classically characterized by obsessions (recurrent, intrusive and unwanted thoughts) and compulsions (excessive, repetitive and ritualistic behaviors or mental acts). OCD is heterogeneous in its clinical presentation and not all patients respond to first-line treatments. Several neurocircuit models of OCD have been proposed with the aim of providing a better understanding of the neural and cognitive mechanisms involved in the disorder. These models use advances in neuroscience and findings from neuropsychological and neuroimaging studies to suggest links between clinical profiles that reflect the symptoms and experiences of patients and dysfunctions in specific neurocircuits. Several models propose that treatments for OCD could be improved if directed to specific neurocircuit dysfunctions, thereby restoring efficient neurocognitive function and ameliorating the symptomatology of each associated clinical profile. Yet, there are several important limitations to neurocircuit models of OCD. The purpose of the current review is to highlight some of these limitations, including issues related to the complexity of brain and cognitive function, the clinical presentation and course of OCD, etiological factors, and treatment methods proposed by the models. We also provide suggestions for future research to advance neurocircuit models of OCD and facilitate translation to clinical application.
Palavras-chave
Obsessive-compulsive disorder, clinical presentation, neurocircuit models, neurobiology, treatment advances
Referências
  1. Alvarenga PG, 2016, EUR CHILD ADOLES PSY, V25, P175, DOI 10.1007/s00787-015-0723-3
  2. Alvarenga PG, 2015, J PSYCHIATR RES, V62, P108, DOI 10.1016/j.jpsychires.2015.01.018
  3. Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003
  4. Attwells S, 2017, JAMA PSYCHIAT, V74, P833, DOI 10.1001/jamapsychiatry.2017.1567
  5. Ay R, 2018, PSYCHIAT RES, V261, P132, DOI 10.1016/j.psychres.2017.12.054
  6. Baumeister S, 2014, NEUROIMAGE, V94, P349, DOI 10.1016/j.neuroimage.2014.01.023
  7. Beucke JC, 2013, JAMA PSYCHIAT, V70, P619, DOI 10.1001/jamapsychiatry.2013.173
  8. Bhikram T, 2020, J PSYCHIATR RES, V123, P128, DOI 10.1016/j.jpsychires.2020.01.019
  9. Bloch MH, 2013, DEPRESS ANXIETY, V30, P716, DOI 10.1002/da.22103
  10. Boedhoe PSW, 2020, AM J PSYCHIAT, V177, P834, DOI 10.1176/appi.ajp.2020.19030331
  11. Boedhoe PSW, 2018, AM J PSYCHIAT, V175, P453, DOI 10.1176/appi.ajp.2017.17050485
  12. van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012
  13. van den Heuvel OA, 2016, EUR NEUROPSYCHOPHARM, V26, P810, DOI 10.1016/j.euroneuro.2015.12.005
  14. Vink JJT, 2018, HUM BRAIN MAPP, V39, P4580, DOI 10.1002/hbm.24307
  15. Visser HA, 2014, J CLIN PSYCHIAT, V75, P1034, DOI 10.4088/JCP.13m08825
  16. Weeland CJ, 2021, J AM ACAD CHILD PSY, V60, P470, DOI 10.1016/j.jaac.2020.03.012
  17. Westwell-Roper C, 2019, J CHILD ADOL PSYCHOP, V29, P615, DOI 10.1089/cap.2018.0140
  18. Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028
  19. Brakoulias V, 2017, COMPR PSYCHIAT, V76, P79, DOI 10.1016/j.comppsych.2017.04.002
  20. Woo CW, 2017, NAT NEUROSCI, V20, P365, DOI 10.1038/nn.4478
  21. Ziegler G, 2019, NAT NEUROSCI, V22, P992, DOI 10.1038/s41593-019-0394-3
  22. Ferreira GM, 2017, CNS SPECTRUMS, V22, P295, DOI 10.1017/S1092852916000535
  23. Brem S, 2012, J NEURAL TRANSM, V119, P1425, DOI 10.1007/s00702-012-0813-z
  24. Brooks SJ, 2016, BRIT J PSYCHIAT, V208, P34, DOI 10.1192/bjp.bp.114.162610
  25. Bruin WB, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-01013-y
  26. Brunoni AR, 2019, BRAZ J PSYCHIAT, V41, P70, DOI 10.1590/1516-4446-2017-0018
  27. Busatto GF, 2001, J AM ACAD CHILD PSY, V40, P347, DOI 10.1097/00004583-200103000-00015
  28. Cao RX, 2021, PROG NEURO-PSYCHOPH, V104, DOI 10.1016/j.pnpbp.2020.110037
  29. Carlisi CO, 2017, BIOL PSYCHIAT, V82, P83, DOI 10.1016/j.biopsych.2016.10.006
  30. Choi EY, 2017, NEUROIMAGE, V146, P821, DOI 10.1016/j.neuroimage.2016.09.037
  31. Cohen MX, 2014, J NEUROSCI, V34, P8988, DOI 10.1523/JNEUROSCI.0261-14.2014
  32. Colclough GL, 2017, ELIFE, V6, DOI 10.7554/eLife.20178
  33. Figee M, 2013, NAT NEUROSCI, V16, P386, DOI 10.1038/nn.3344
  34. de Mathis MA, 2013, EUR NEUROPSYCHOPHARM, V23, P594, DOI 10.1016/j.euroneuro.2012.08.006
  35. de Wit SJ, 2015, PSYCHOL MED, V45, P3059, DOI 10.1017/S0033291715001026
  36. de Wit SJ, 2012, AM J PSYCHIAT, V169, P1100, DOI 10.1176/appi.ajp.2012.12010073
  37. Delorme R, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-1
  38. Demuru M, 2020, COMPUT BIOL MED, V120, DOI 10.1016/j.compbiomed.2020.103748
  39. Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073
  40. do Rosario-Campos MC, 2001, AM J PSYCHIAT, V158, P1899, DOI 10.1176/appi.ajp.158.11.1899
  41. Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005
  42. Dougherty DD, 2018, JAMA PSYCHIAT, V75, P1081, DOI 10.1001/jamapsychiatry.2018.0930
  43. Elliott ML, 2020, PSYCHOL SCI, V31, P792, DOI 10.1177/0956797620916786
  44. Fontenelle LF, 2003, J PSYCHIATR RES, V37, P127, DOI 10.1016/S0022-3956(02)00087-0
  45. Elliott ML, 2019, NEUROIMAGE, V189, P516, DOI 10.1016/j.neuroimage.2019.01.068
  46. Eshel N, 2020, NEUROPSYCHOPHARMACOL, V45, P1018, DOI 10.1038/s41386-020-0633-z
  47. Foss-Feig JH, 2017, BIOL PSYCHIAT, V81, P848, DOI 10.1016/j.biopsych.2017.03.005
  48. Fullana MA, 2018, NEUROSCI BIOBEHAV R, V88, P16, DOI 10.1016/j.neubiorev.2018.03.002
  49. Gomez DEP, 2020, NEUROIMAGE, V218, DOI 10.1016/j.neuroimage.2020.116783
  50. Gratton C, 2018, NEURON, V98, P439, DOI 10.1016/j.neuron.2018.03.035
  51. Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6
  52. Grent-'t-Jong T, 2020, JAMA PSYCHIAT, V77, P852, DOI 10.1001/jamapsychiatry.2020.0284
  53. Groom MJ, 2015, BRAIN COGNITION, V97, P1, DOI 10.1016/j.bandc.2015.04.004
  54. Mataix-Cols D, 2004, ARCH GEN PSYCHIAT, V61, P564, DOI 10.1001/archpsyc.61.6.564
  55. Grutzmann R, 2016, BIOL PSYCHIAT, V80, P562, DOI 10.1016/j.biopsych.2014.12.010
  56. Hemmings SMJ, 2013, J PSYCHIATR RES, V47, P1857, DOI 10.1016/j.jpsychires.2013.08.012
  57. Hemmings SMJ, 2004, PSYCHIAT RES, V128, P175, DOI 10.1016/j.psychres.2004.05.007
  58. Hibar DP, 2018, BRIT J PSYCHIAT, V213, P430, DOI 10.1192/bjp.2018.62
  59. Hoexter MQ, 2018, J PSYCHIATR RES, V96, P224, DOI 10.1016/j.jpsychires.2017.10.009
  60. Hojgaard DRMA, 2017, EUR CHILD ADOLES PSY, V26, P281, DOI 10.1007/s00787-016-0887-5
  61. Hollander E, 1997, CNS SPECTRUMS, V2, P16, DOI 10.1017/S1092852900011068
  62. Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]
  63. Huang MH, 2021, PSYCHOL MED, V51, P680, DOI 10.1017/S0033291719003696
  64. Huyser C, 2014, WORLD J BIOL PSYCHIA, V15, P443, DOI 10.3109/15622975.2013.819122
  65. Mataix-Cols D, 2002, AM J PSYCHIAT, V159, P263, DOI 10.1176/appi.ajp.159.2.263
  66. Jacobs GR, 2021, NEUROPSYCHOPHARMACOL, V46, P643, DOI 10.1038/s41386-020-00902-6
  67. Jocham G, 2009, NEUROSCI BIOBEHAV R, V33, P48, DOI 10.1016/j.neubiorev.2008.08.011
  68. Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523
  69. Klaassens BL, 2015, NEUROIMAGE, V122, P440, DOI 10.1016/j.neuroimage.2015.08.012
  70. Klawohn J, 2020, INT J PSYCHOPHYSIOL, V156, P79, DOI 10.1016/j.ijpsycho.2020.07.005
  71. Kushki A, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0631-2
  72. Kwak S, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-01045-4
  73. LEONARD HL, 1992, AM J PSYCHIAT, V149, P1244
  74. Li X, 2017, NATURE, V550, P239, DOI 10.1038/nature24267
  75. Light GA, 2017, NEUROPSYCHOPHARMACOL, V42, P2633, DOI 10.1038/npp.2017.81
  76. Mataix-Cols D, 2013, JAMA PSYCHIAT, V70, P709, DOI 10.1001/jamapsychiatry.2013.3
  77. Lochner C, 2002, DEPRESS ANXIETY, V15, P66, DOI 10.1002/da.10028
  78. de Barros PMF, 2021, EUR CHILD ADOLES PSY, V30, P89, DOI 10.1007/s00787-020-01495-7
  79. Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794
  80. McGregor NW, 2016, PSYCHIAT RES, V246, P527, DOI 10.1016/j.psychres.2016.10.044
  81. Miguel EC, 2000, J CLIN PSYCHIAT, V61, P150, DOI 10.4088/JCP.v61n0213
  82. Milad MR, 2012, TRENDS COGN SCI, V16, P43, DOI 10.1016/j.tics.2011.11.003
  83. Miller G, 2006, SCIENCE, V311, P458, DOI 10.1126/science.311.5760.458
  84. Moody TD, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.192
  85. Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17
  86. Shalbafan M, 2015, PHARMACOPSYCHIATRY, V48, P136, DOI 10.1055/s-0035-1549929
  87. Norman LJ, 2019, BIOL PSYCHIAT, V85, P713, DOI 10.1016/j.biopsych.2018.11.010
  88. Norman LJ, 2016, JAMA PSYCHIAT, V73, P815, DOI 10.1001/jamapsychiatry.2016.0700
  89. Pallanti Stefano, 2011, Front Psychiatry, V2, P70, DOI 10.3389/fpsyt.2011.00070
  90. Paul S, 2019, PSYCHOL MED, V49, P278, DOI 10.1017/S003329171800079X
  91. Perera MPN, 2019, J ANXIETY DISORD, V62, P1, DOI 10.1016/j.janxdis.2018.11.001
  92. Piacentini J, 2003, J CHILD ADOL PSYCHOP, V13, pS61, DOI 10.1089/104454603322126359
  93. Pico-Perez M, 2019, NEUROSCI BIOBEHAV R, V104, P102, DOI 10.1016/j.neubiorev.2019.06.029
  94. Pico-Perez M, 2020, NEUROSCI BIOBEHAV R, V112, P83, DOI 10.1016/j.neubiorev.2020.01.033
  95. Pillinger T, 2019, PSYCHOPHARMACOLOGY, V236, P1985, DOI 10.1007/s00213-019-5188-5
  96. Qiu Y, 2010, SCAND J IMMUNOL, V72, P425, DOI 10.1111/j.1365-3083.2010.02456.x
  97. Shephard E, 2021, MOL PSYCHIATR, V26, P4583, DOI 10.1038/s41380-020-01007-8
  98. Radua J, 2010, ARCH GEN PSYCHIAT, V67, P701, DOI 10.1001/archgenpsychiatry.2010.70
  99. Rappel P, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0165-z
  100. RETTEW DC, 1992, J AM ACAD CHILD PSY, V31, P1050, DOI 10.1097/00004583-199211000-00009
  101. Riesel A, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13348
  102. Riesel A, 2015, AM J PSYCHIAT, V172, P665, DOI 10.1176/appi.ajp.2014.14070886
  103. Riesel A, 2014, EUR ARCH PSY CLIN N, V264, P707, DOI 10.1007/s00406-014-0499-3
  104. Riesel A, 2011, AM J PSYCHIAT, V168, P317, DOI 10.1176/appi.ajp.2010.10030416
  105. Rufer M, 2005, J AFFECT DISORDERS, V88, P99, DOI 10.1016/j.jad.2005.06.003
  106. Salum GA, 2015, INT J METH PSYCH RES, V24, P58, DOI 10.1002/mpr.1459
  107. Saraiva Leonardo Cardoso, 2020, Fac Rev, V9, P30, DOI 10.12703/r/9-30
  108. Shin DJ, 2014, BIOL PSYCHIAT, V75, P606, DOI 10.1016/j.biopsych.2013.09.002
  109. Sayyah M, 2011, PSYCHIAT RES, V189, P403, DOI 10.1016/j.psychres.2011.01.019
  110. Schreck M, 2020, CHILD PSYCHIAT HUM D, DOI [10.1007/s10578-020-01075-5, DOI 10.1007/S10578-020-01075-5]
  111. Simpson HB, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-2439-2
  112. Singh F, 2020, NEUROIMAGE-CLIN, V27, DOI 10.1016/j.nicl.2020.102339
  113. Skoog G, 1999, ARCH GEN PSYCHIAT, V56, P121, DOI 10.1001/archpsyc.56.2.121
  114. Smit DJA, 2020, AM J MED GENET B, V183, P208, DOI 10.1002/ajmg.b.32777
  115. Sobin C, 2000, COMPR PSYCHIAT, V41, P373, DOI 10.1053/comp.2000.9009
  116. Stein DJ, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0102-3
  117. Storch EA, 2008, J AM ACAD CHILD PSY, V47, P583, DOI 10.1097/CHI.0b013e31816774b1
  118. Boedhoe PSW, 2017, AM J PSYCHIAT, V174, P60, DOI 10.1176/appi.ajp.2016.16020201
  119. Storch EA, 2006, J CLIN CHILD ADOLESC, V35, P446, DOI 10.1207/s15374424jccp3503_10
  120. Subira M, 2015, J PSYCHIATR NEUROSCI, V40, P232, DOI 10.1503/jpn.140118
  121. Suchdev PS, 2017, PEDIATRICS, V139, DOI [10.1542/peds.2016-2828E, 10.1542/peds.2016-2828e]
  122. Sunol M, 2021, J AM ACAD CHILD PSY, V60, P757, DOI 10.1016/j.jaac.2020.08.435
  123. Tang W, 2019, ELIFE, V8, DOI 10.7554/eLife.43761
  124. Thornicroft G, 2016, WORLD PSYCHIATRY, V15, P276, DOI 10.1002/wps.20349
  125. Thorsen AL, 2020, NEUROIMAGE-CLIN, V28, DOI 10.1016/j.nicl.2020.102460
  126. Thorsen AL, 2018, BIOL PSYCHIAT-COGN N, V3, P563, DOI 10.1016/j.bpsc.2018.01.009
  127. Tibi L, 2020, J AFFECT DISORDERS, V264, P206, DOI 10.1016/j.jad.2019.12.028
  128. Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024
  129. Boger S, 2020, EUR J PSYCHOTRAUMATO, V11, DOI 10.1080/20008198.2020.1753942
  130. Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020
  131. Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002
  132. Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774